Expertise in
4
conditions

Dr. Matthew M. Poppe

Radiation Oncology
1950 Circle Of Hope Drive, Oncology, Suite 6700, 
Salt Lake City, UT 
Accepting New Patients
Referral may be required
Before you request
Expertise in
4
conditions
1950 Circle Of Hope Drive, Oncology, Suite 6700, 
Salt Lake City, UT 

Overview

Matthew Poppe is a Radiation Oncologist practicing medicine in Salt Lake City, Utah.

Dr. Poppe is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Endometrial Cancer, Intraductal Papilloma, and Adult Soft Tissue Sarcoma.

Dr. Poppe is board certified in American Board Of Radiology. He is actively involved in clinical research, co-authoring 55 peer reviewed articles and participating in 7 clinical trials. Dr. Poppe is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Family Medicine in AK

Board Certifications

American Board Of Radiology

Hospital Affiliations

University Of Utah Hospital And Clinics

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Regence
  • EPO
  • PPO
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Huntsman Cancer Hospital
1950 Circle Of Hope Drive, Oncology, Suite 6700, Salt Lake City, UT 84112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
A Phase 1b Study of Berzosertib in Combination With Radiation Therapy to Overcome Therapeutic Resistance in Chemotherapy Resistant Triple Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer
A Phase 1b Study of Berzosertib in Combination With Radiation Therapy to Overcome Therapeutic Resistance in Chemotherapy Resistant Triple Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Other, Radiation, Drug, Procedure
Study Drug: Berzosertib
Study Phase: Phase 1
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Radiation, Other
Study Phase: Phase 3
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
NOVEMBER (Novem- (9), BrEast Radiation), A Phase II Trial of a 9 Day Course of Whole Breast Radiotherapy for Early Stage Breast Cancer
NOVEMBER (Novem- (9), BrEast Radiation), A Phase II Trial of a 9 Day Course of Whole Breast Radiotherapy for Early Stage Breast Cancer
Enrollment Status: Completed
Publish Date: December 30, 2025
Intervention Type: Radiation
Study Phase: Phase 2
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Other, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, Paclitaxel
Study Phase: Phase 3
View 6 Less Clinical Trials

55 Total Publications

Concurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III Trial.
Concurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 11, 2026
Similar Doctors
Expertise in
10
conditions
Dr. David K. Gaffney
Radiation Oncology
Expertise in
10
conditions
Dr. David K. Gaffney
Radiation Oncology
Referral may be required

Radiation Oncology - Sugarhouse

1280 E Stringham Ave, 
Salt Lake City, UT 
 (3.8 miles away)
801-581-2396
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Gaffney is a Radiation Oncologist practicing medicine in Salt Lake City, Utah. Dr. Gaffney is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Endometrial Cancer, Vulvar Cancer, and Breast Cancer. Dr. Gaffney is board certified in American Board Of Radiology. Dr. Gaffney is currently accepting new patients.

Expertise in
6
conditions
Dr. Jonathan D. Tward
Radiation Oncology
Expertise in
6
conditions
Dr. Jonathan D. Tward
Radiation Oncology
Referral may be required

Radiation Oncology - Sugarhouse

1280 E Stringham Ave, 
Salt Lake City, UT 
 (3.8 miles away)
801-581-2396
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonathan Tward is a Radiation Oncologist practicing medicine in Salt Lake City, Utah. Dr. Tward is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Prostatectomy, and Reconstructive Urology Surgery. Dr. Tward is board certified in American Board Of Radiology. Dr. Tward is currently accepting new patients.

Expertise in
8
conditions
Dr. Dennis C. Shrieve
Radiation Oncology
Expertise in
8
conditions
Dr. Dennis C. Shrieve
Radiation Oncology
Referral may be required

Radiation Oncology - Sugarhouse

1280 E Stringham Ave, 
Salt Lake City, UT 
 (3.8 miles away)
801-581-2396
Languages Spoken:
English
Accepting New Patients

Dennis Shrieve is a Radiation Oncologist practicing medicine in Salt Lake City, Utah. Dr. Shrieve is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Meningioma, Radiation Induced Meningioma, Gliosarcoma, Prostatectomy, and Microvascular Decompression. Dr. Shrieve is board certified in American Board Of Radiology. Dr. Shrieve is currently accepting new patients.

Frequently Asked Questions about Dr. Matthew M. Poppe

How do I make an appointment with Dr. Matthew M. Poppe?

You can book an appointment with Dr. Matthew M. Poppe by calling their office at 801-581-2396. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Matthew M. Poppe a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew M. Poppe is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Matthew M. Poppe specialize in?

While Dr. Matthew M. Poppe is a Radiation Oncology, they have specific expertise in Breast Cancer, Endometrial Cancer, and Intraductal Papilloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Matthew M. Poppe participate in research or clinical trials?

Yes. Dr. Matthew M. Poppe has published 55 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Matthew M. Poppe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Matthew M. Poppe accept my insurance?

Dr. Matthew M. Poppe accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 801-581-2396 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Poppe's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile